GH
Price
$59.72
Change
-$0.06 (-0.10%)
Updated
Sep 23 closing price
Capitalization
7.45B
36 days until earnings call
RGEN
Price
$123.95
Change
-$1.99 (-1.58%)
Updated
Sep 23 closing price
Capitalization
6.97B
41 days until earnings call
Interact to see
Advertisement

GH vs RGEN

Header iconGH vs RGEN Comparison
Open Charts GH vs RGENBanner chart's image
Guardant Health
Price$59.72
Change-$0.06 (-0.10%)
Volume$2.24M
Capitalization7.45B
Repligen
Price$123.95
Change-$1.99 (-1.58%)
Volume$598.91K
Capitalization6.97B
GH vs RGEN Comparison Chart in %
Loading...
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GH vs. RGEN commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GH is a Buy and RGEN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (GH: $59.72 vs. RGEN: $123.95)
Brand notoriety: GH: Notable vs. RGEN: Not notable
GH represents the Medical Specialties, while RGEN is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: GH: 83% vs. RGEN: 70%
Market capitalization -- GH: $7.45B vs. RGEN: $6.97B
GH [@Medical Specialties] is valued at $7.45B. RGEN’s [@Pharmaceuticals: Other] market capitalization is $6.97B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $160.51B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.62B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GH’s FA Score shows that 0 FA rating(s) are green whileRGEN’s FA Score has 1 green FA rating(s).

  • GH’s FA Score: 0 green, 5 red.
  • RGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, RGEN is a better buy in the long-term than GH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GH’s TA Score shows that 4 TA indicator(s) are bullish while RGEN’s TA Score has 6 bullish TA indicator(s).

  • GH’s TA Score: 4 bullish, 4 bearish.
  • RGEN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, RGEN is a better buy in the short-term than GH.

Price Growth

GH (@Medical Specialties) experienced а +7.80% price change this week, while RGEN (@Pharmaceuticals: Other) price change was +3.51% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.43%. For the same industry, the average monthly price growth was +3.59%, and the average quarterly price growth was +23.15%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.06%. For the same industry, the average monthly price growth was -1.49%, and the average quarterly price growth was +7.32%.

Reported Earning Dates

GH is expected to report earnings on Oct 30, 2025.

RGEN is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Medical Specialties (+0.43% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-1.06% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GH($7.45B) has a higher market cap than RGEN($6.97B). GH YTD gains are higher at: 95.483 vs. RGEN (-13.888). RGEN has higher annual earnings (EBITDA): 99.5M vs. GH (-368.35M). RGEN has more cash in the bank: 709M vs. GH (629M). RGEN has less debt than GH: RGEN (686M) vs GH (1.33B). GH has higher revenues than RGEN: GH (829M) vs RGEN (674M).
GHRGENGH / RGEN
Capitalization7.45B6.97B107%
EBITDA-368.35M99.5M-370%
Gain YTD95.483-13.888-688%
P/E RatioN/A521.44-
Revenue829M674M123%
Total Cash629M709M89%
Total Debt1.33B686M194%
FUNDAMENTALS RATINGS
GH vs RGEN: Fundamental Ratings
GH
RGEN
OUTLOOK RATING
1..100
119
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10092
PRICE GROWTH RATING
1..100
4060
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
2550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GH's Valuation (76) in the Medical Or Nursing Services industry is in the same range as RGEN (95) in the Biotechnology industry. This means that GH’s stock grew similarly to RGEN’s over the last 12 months.

GH's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as RGEN (100) in the Biotechnology industry. This means that GH’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's SMR Rating (92) in the Biotechnology industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that RGEN’s stock grew similarly to GH’s over the last 12 months.

GH's Price Growth Rating (40) in the Medical Or Nursing Services industry is in the same range as RGEN (60) in the Biotechnology industry. This means that GH’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for GH (100) in the Medical Or Nursing Services industry. This means that RGEN’s stock grew significantly faster than GH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GHRGEN
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 9 days ago
75%
Declines
ODDS (%)
Bearish Trend 10 days ago
83%
Bearish Trend 13 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
APPX122.272.60
+2.17%
Tradr 2X Long APP Daily ETF
FUSI50.72-0.01
-0.02%
American Century Multisector Flt Inc ETF
LGI17.60-0.05
-0.28%
Lazard Global Total Return & Income Fund
STRV43.06-0.23
-0.53%
Strive 500 ETF
ADBG11.53-0.14
-1.20%
Leverage Shares 2X Long ADBE Daily ETF

GH and

Correlation & Price change

A.I.dvisor indicates that over the last year, GH has been loosely correlated with NTRA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if GH jumps, then NTRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GH
1D Price
Change %
GH100%
-0.10%
NTRA - GH
57%
Loosely correlated
-3.55%
VCYT - GH
54%
Loosely correlated
+0.65%
TWST - GH
47%
Loosely correlated
-0.61%
RGEN - GH
41%
Loosely correlated
-1.58%
GKOS - GH
41%
Loosely correlated
+0.08%
More

RGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGEN has been closely correlated with DHR. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if RGEN jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGEN
1D Price
Change %
RGEN100%
-1.58%
DHR - RGEN
67%
Closely correlated
-0.39%
A - RGEN
66%
Loosely correlated
-0.31%
BIO - RGEN
63%
Loosely correlated
-0.46%
MTD - RGEN
61%
Loosely correlated
-0.08%
BLFS - RGEN
59%
Loosely correlated
-2.10%
More